Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Treasury Shares (2020 - 2025)

Historic Treasury Shares for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to $353743.0.

  • Mirum Pharmaceuticals' Treasury Shares rose 2414.0% to $353743.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $353743.0, marking a year-over-year increase of 2414.0%. This contributed to the annual value of $284955.0 for FY2024, which is 9275.21% up from last year.
  • Latest data reveals that Mirum Pharmaceuticals reported Treasury Shares of $353743.0 as of Q3 2025, which was up 2414.0% from $353743.0 recorded in Q2 2025.
  • In the past 5 years, Mirum Pharmaceuticals' Treasury Shares ranged from a high of $353743.0 in Q1 2025 and a low of $22270.0 during Q3 2022
  • In the last 5 years, Mirum Pharmaceuticals' Treasury Shares had a median value of $205960.0 in 2021 and averaged $210432.2.
  • Per our database at Business Quant, Mirum Pharmaceuticals' Treasury Shares crashed by 8571.19% in 2022 and then skyrocketed by 12091.88% in 2024.
  • Quarter analysis of 5 years shows Mirum Pharmaceuticals' Treasury Shares stood at $122464.0 in 2021, then tumbled by 81.82% to $22270.0 in 2022, then skyrocketed by 563.83% to $147835.0 in 2023, then skyrocketed by 92.75% to $284955.0 in 2024, then rose by 24.14% to $353743.0 in 2025.
  • Its last three reported values are $353743.0 in Q3 2025, $353743.0 for Q2 2025, and $353743.0 during Q1 2025.